Schrödinger will be at the 2nd RSC – BMCS Fragment-Based Drug Discovery meeting, taking place March 4–5, in Alderley Park, UK. Schrödinger Applications Scientist Dr. Daniel Robinson will present a poster titled "Energy-based pharmacophore hypotheses derived from fragment docking."